ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1147

Poverty and Systemic Lupus International Collaborating Clinics Damage Index (SDI) Are Significant Risk Factors for Hospitalization in SLE Patients

Allen Anandarajah1, Caroline Thirukumaran 1, Kelly callahan 1, Jennifer Anolik 1 and Christopher Ritchlin 2, 1University of Rochester Medical Center, Rochester, NY, 2Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: hospitalization, poverty and slicc damage index, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Healthcare Disparities In Rheumatology Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is associated with a high rate of hospitalizations and is the sixth highest reason for 30-day readmissions among all medical conditions in the USA. In SLE patients, lower socioeconomic status correlates with poorer disease outcomes and a higher mortality rate but whether poverty is a risk factor for hospitalization is not clearly understood.
To identify the impact of poverty as a risk factor for hospitalizations in SLE patients.

Methods: We designed a single center, retrospective study of SLE patients hospitalized to Strong Memorial Hospital in Rochester, New York. Billing data was analyzed to identify all hospitalizations that included an ICD-10 code for SLE as primary or secondary diagnosis for the period between July 1, 2013 and June 30, 2017. A diagnosis of SLE was confirmed by evaluating for the presence of American College Rheumatology Criteria or was assigned by a rheumatologist. The outcomes were high-risk patients (defined as those with 3 or more admissions per year) and we collected data on length of stay (LOS) and cost of admissions. The key independent variable was poverty based on the patient resident zip code. Areas of poverty were as defined by the Finger Lakes Health Systems Agency. Bivariate analysis followed by multivariable regression models that controlled for important patient-level confounders such as age, gender, race/ ethnicity, body mass index, disease activity measures (complements, dsDNA, Systemic Lupus International Collaborating Clinics Damage Index (SDI) and comorbidity index (CMI) were applied to assess the data.

Results: A total of 202 patients with SLE were admitted over the 4 year study period and 68 of these subjects were from zip codes associated with poverty. On bivariate analysis we found that patients living in the poverty associated zip codes were significantly more likely to be categorized as high risk patients (p=0.01) and were of African American origin (p=0.001). We also noted significantly higher median dsDNA levels among subjects from the areas associated with poverty (11.2) compared to patients from other zip codes (4.6) (p=0.01). No significant differences were noted for age, SDI, complement levels, total and average LOS as well as total and average cost of admissions between the two groups. We then created multivariable regression models to assess impact of poverty on the above mentioned outcomes of interest. Patients residing in areas with poverty associated zip codes were significantly more likely to be classified as high risk patients (OR 2.96; CI 1.09, 9.00; p=0.03) with higher SDI scores (OR 1.39; CI 1.07, 1.81; p=0.01). SDI was associated with significant risk for admissions (OR 1.26; P< 0.01), average cost above the median (OR 1.65; p< 0.01) and average LOS above the median (OR 1.37; p=0.01). Analysis focused on the African American population revealed that living in poverty areas remained a significant risk factor for hospitalization (p=0.04).

Conclusion: Socioeconomic factors and damage index are significant risk factors for hospitalizations in SLE patients. Early initiation of therapy, addressing the challenges of poverty and overcoming healthcare disparities are important goals to improve the health of lupus patients.


Disclosure: A. Anandarajah, None; C. Thirukumaran, None; K. callahan, None; J. Anolik, None; C. Ritchlin, AbbVie, 2, 5, 9, Amgen, 2, 5, BMS, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Lilly, 5, Novartis, 5, Pfizer, 2, Pfizer Inc, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Anandarajah A, Thirukumaran C, callahan K, Anolik J, Ritchlin C. Poverty and Systemic Lupus International Collaborating Clinics Damage Index (SDI) Are Significant Risk Factors for Hospitalization in SLE Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/poverty-and-systemic-lupus-international-collaborating-clinics-damage-index-sdi-are-significant-risk-factors-for-hospitalization-in-sle-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/poverty-and-systemic-lupus-international-collaborating-clinics-damage-index-sdi-are-significant-risk-factors-for-hospitalization-in-sle-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology